Authors’ reply: Serum Albumin for Tuberculosis in HIV Infected Patients Eligible for Antiretroviral Therapy

Predictors of CD4+ cell count response and of adverse outcome among HIV-infected patients receiving highly active antiretroviral therapy in a public hospital in Peru.. Falster

Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV- infected patients after the introduction of highly active antiretroviral therapy. Euro SIDA Study

The use of antiretroviral therapy (ART) in these patients reduces the risk of developing active TB [32,33,34], being associated in HIV-infected TB patients with higher rates

ation and management of dyslipidemia in human immuno- defi ciency virus (HIV)-infected adults receiving antiretroviral therapy: Recommendations of the HIV Medicine Association

Evaluation of Viral Resistance to Reverse Transcriptase Inhibitors (RTI) in HIV-1- Infected Patients Before and After 6 Months of Single or Double Antiretroviral Therapy..

Objective : To evaluate the prevalence of and the associated factors for metabolic syndrome (MS) among Latin American HIV-infected patients receiving antiretroviral therapy (ART)

Tuberculosis is one of the leading causes of development of Immune reconstitution inflamma- tory syndrome (IRIS) in HIV patients receiving antiretroviral therapy (ART).. Objective: To

active antiretroviral therapy are at higher risk of cardiovascular diseases than human immunodeficiency virus infected patients not receiving highly active antiretroviral therapy,